Vascular Solutions, Inc.  

(Public, NASDAQ:VASC)   Watch this stock  
Find more results for CHARMAINE WILLIAMS´┐Ż
-0.87 (-3.41%)
Real-time:   2:16PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 24.34 - 25.57
52 week 24.34 - 40.33
Open 25.04
Vol / Avg. 75,629.00/140,315.00
Mkt cap 432.09M
P/E 42.29
Div/yield     -
EPS 0.58
Shares 17.36M
Beta 0.66
Inst. own 77%
Apr 29, 2016
Vascular Solutions Inc Annual Shareholders Meeting (Estimated) - 2:30PM EDT - Add to calendar
Apr 19, 2016
Q1 2016 Vascular Solutions Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jan 21, 2016
Q4 2015 Vascular Solutions Inc Earnings Call
Jan 21, 2016
Q4 2015 Vascular Solutions Inc Earnings Release
Dec 1, 2015
Vascular Solutions Inc at Piper Jaffray Healthcare Conference
Nov 19, 2015
Vascular Solutions Inc at Canaccord Genuity Medical Technology & Diagnostics Forum
Nov 17, 2015
Vascular Solutions Inc at Stifel Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 4.09% 7.11%
Operating margin 0.42% 9.24%
EBITD margin - 13.31%
Return on average assets 4.34% 7.71%
Return on average equity 4.94% 8.67%
Employees 485 -
CDP Score - -


6464 Sycamore Ct N
MAPLE GROVE, MN 55369-6032
United States - Map
+1-763-6564300 (Phone)
+1-877-6564251 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Vascular Solutions, Inc. is a medical device company, which creates minimally invasive medical devices and then delivers these products and services to physicians through its direct domestic sales force and its international distribution network. It offers products and services in three categories: Catheter products, which consist of catheters used in minimally invasive medical procedures for the treatment of vascular conditions, such as GuideLiner and Pronto extraction catheters and includes micro-introducer kits for gaining percutaneous access to the vasculature; Hemostat products, which consist of the D-Stat Dry hemostat to control surface bleeding, D-Stat Flowable for preventing bleeding in subcutaneous pockets, Accumed wrist positioning splints and Vasc Band inflatable compression bands, and Vein products, which consist of the Vari-Lase endovenous laser for the treatment of varicose veins and a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter.

Officers and directors

John L. Erb Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Howard C. Root Chief Executive Officer and Director
Age: 54
Bio & Compensation  - Reuters
James Hennen Chief Financial Officer, Senior Vice President - Finance, Corporate Secretary
Age: 42
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
William Rutstein Senior Vice President - International Sales
Age: 62
Bio & Compensation  - Reuters
Brent Binkowski Senior Vice President - Operations
Age: 46
Bio & Compensation  - Reuters
Chad J. Kugler Senior Vice President - Research and Development
Age: 43
Bio & Compensation  - Reuters
Charmaine Sutton Senior Vice President - Regulatory and Quality Assurance
Age: 55
Bio & Compensation  - Reuters
Susan Christian Vice President - Sales Operations
Age: 45
Bio & Compensation  - Reuters
Carrie Powers Vice President - Marketing
Age: 40
Bio & Compensation  - Reuters
Phillip E. Nalbone Vice President - Corporate Development
Age: 52
Bio & Compensation  - Reuters